# FDA recall D-576-2013

> **Novartis Consumer Health** · Class III · drug recall initiated 2013-02-19.

## Product

Lamisil AT Cream (terbinafine hydrochloride 1% antifungal), 12 gm ( .42 oz) Tubes and 30 gm (1 oz) Tubes packaged in one box,  Novartis Consumer Health, Inc., Parsitan, NJ. UPC code: 300676249438.  (Club Pack), NDC 0067-6295-43

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

## Distribution

Nationwide and Puerto Rico, and Panama.  Military distribution made.

## Key facts

- **Recall number:** D-576-2013
- **Recalling firm:** Novartis Consumer Health
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-19
- **Report date:** 2013-06-12
- **Termination date:** 2014-11-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lincoln, NE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-576-2013

## Citation

> AI Analytics. FDA recall D-576-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-576-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*